mayne pharma
Mayne Pharma Collapses 30% as Treasurer Flags National-Interest Block in Cosette Deal
Mayne Pharma in Freefall: Regulatory Hurdle Threatens $672 m Buy-out Mayne Pharma (ASX: MYX) has suddenly become one of the most talked-about stocks on the ASX after the federal Treasurer raised serious national-interest concerns about its proposed takeover by Cosette Pharmaceuticals. The company that looked like it was on the cusp of being acquired is now…
curvebeam
CurveBeam AI Rockets 28% After China Deal Opens Door to 38,000 Hospitals
Could CurveBeam Be The Next 4DMedical CurveBeam AI’s share price jumped 28% today after the company released its quarterly update and announced a major partnership in China with Weiying Intelligent Medical Technology, a joint venture with Wego Orthopedics. This agreement marks a significant step forward in CurveBeam’s international expansion, opening the door to one of…
St George Mining
St George Mining Back in the Spotlight as US Looks to Brazil for Rare-Earth Security
St George Mining Jumps 4% as US–Brazil Talks Boost Hopes for Rare-Earth Partnership Potentially exciting news for St George Mining (ASX: SGQ) today, with shares climbing 4 percent after reports that a senior U.S. official met with Brazilian mining executives to discuss rare-earth supply partnerships. The meeting forms part of a broader US initiative to…
google
Google Hits Historic $100 Billion Quarter as AI and Cloud Drive Record Growth
Alphabet Delivers First-Ever USD 100 Billion Quarter Google delivered a standout performance this quarter, with the stock rising 3 percent and momentum likely to continue in the near term. Among the Magnificent Seven, Google is showing some of the earliest and clearest signs of turning its high capital expenditure into real business value. What separates…
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here